This study used immunohistochemical analysis of SOX4 and p16 expression in patients with ATLL and PTCL-NOS to determine whether these factors may be helpful to discriminate between these diseases. This evidence concerns the gene CDKN2A and mature T-cell and NK-cell non-Hodgkin lymphoma.